Value in Health announced the publication of a study showing that United States Medicare could save up to an additional $5-$10 billion dollars annually across 10 drugs if it negotiated prices using a therapeutic reference pricing approach rather than using the statutory ceiling price alone.
Tag: Value in Health
Global Medical Device Panel Finds Little Evidence Linking Health Technology Assessment Processes to Medical Device Purchasing Decisions
Value in Health, the official journal of ISPOR, announced the publication of a systematic literature review showing that there is sparce evidence in the health research literature to link health technology assessment processes and outcomes with device purchasing decisions.
Proposed Drug Pricing Policy Would Save Medicare Between $1 Billion and $2.1 Billion Annually
Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a report that identifies expensive Medicare Part B drugs with low added therapeutic benefit and models a reimbursement policy for them based on domestic reference pricing.
ISPOR’s Value in Health Regional Issues Receives Its First Impact Factor Score
Value in Health Regional Issues, the regionally focused journal of ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), received its first-ever impact factor score this year. Value in Health, one of the top-ranked journals in the HEOR field, maintained its high ranking on the prestigious list.
Expert Panel Publishes Good Practices Recommendations for the Selection, Development, and Modification of Health-Related Performance Outcome Assessments
Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of an ISPOR Good Practices Report providing recommendations on performance outcome (PerfO) assessments.
Global Expert Panel Publishes New Guidance on Measurement Comparability Between Methods of Patient Data Collection Recommending Move Away from Additional Testing
Value in Health, the official journal of ISPOR, announced today the publication of an ISPOR Good Practices Report providing recommendations for assessing the need to demonstrate comparability among ways to collect patient responses.
ISPOR Marks 25th Anniversary of Flagship Journal Value in Health
Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), published an editorial celebrating its 25th anniversary as the Society’s flagship HEOR journal.
Global Expert Panel Publishes New Guidance on Designing, Conducting, and Analyzing Quantitative Benefit-Risk Assessment
Value in Health, the official journal of ISPOR, announced the publication of new good practice guidelines for the design, conduct, analysis, and communication of quantitative benefit-risk assessments (qBRA) to support regulatory decision making of medical products.
New Research Addresses the Drug Pricing Conundrum: Encouraging Innovation While Maintaining Affordability
Value in Health, the official journal of ISPOR, announced the publication of a series of articles describing important new research related to drug pricing globally. The articles were published in the March 2023 issue of the journal.
Global Health Panel Publishes New Recommendations for Assessing Health Technology in Multipayer Healthcare Systems
Value in Health, the official journal of ISPOR, announced the publication of a new report examining the specific challenges of conducting and using health technology assessment in countries with multipayer healthcare systems.
Global Expert Panel Identifies 5 Areas Where Machine Learning Could Enhance Health Economics and Outcomes Research
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new guidance for health economics and outcomes research and decision makers in the use of an important class of artificial intelligence techniques.
New Research Yields Valuable Evidence Regarding the Assessment of Health-Related Quality of Life in Children
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of a series of articles providing new insights on measuring and valuing children’s health-related quality of life.
Remote Patient Monitoring Linked to Multiple Benefits Including Cost-Effectiveness and Improved Outcomes
Value in Health announced the publication of a series of articles assessing the value of remote patient monitoring in addressing challenges in patient care.
Health Preference Researchers Emphasize the Importance of Accounting for Preference Heterogeneity, but Highlight the Need for Guidance
Value in Health announced the publication of a report showing that while there is agreement about the importance of accounting for preference heterogeneity in discrete-choice experiments, there is a clear need for further guidance.
New Research Exposes Important Global Gaps in Coverage and Reimbursement Policies for Medical Nutrition
Value in Health announced the publication of a report showing that most countries provide limited medical nutrition reimbursement, have not updated reimbursement policies, and lack health technology assessment for medical nutrition technologies.
ISPOR Value in Health Themed Section Provides Important Updates on COVID-19 Health Economics
Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a series of articles examining the COVID-19 pandemic from a health economics perspective.
ISPOR’s Flagship Journal Value in Health Demonstrates High Impact
New data released by Clarivate’s Journal Citation Reports show that Value in Health’s impact factor score is 5.725, which represents a 20.6% increase over the previous year,
ISPOR Introduces New Competencies Framework for Health Economics and Outcomes Research Professionals
ISPOR—the professional society for health economics and outcomes research (HEOR), announced the publication of its HEOR Competencies Framework™ that was published in the September 2020 issue of Value in Health.
Supplementary Measles Immunization Activities Provide More Equitable Results Than Routine Measles Immunization Programs
Value in Health announced new research showing that, across 20 low- and middle-income countries, supplementary measles immunization activities tended to provide more equitable vaccination delivery across socioeconomic groups than routine measles immunization programs.
Coming of Age: Emerging Health Preference Research Based on Established Scientific Standards
Value in Health, the official journal of ISPOR, announced today the publication of a series of articles focused on recent developments in the field of health preference research.
ISPOR Working Group Provides a First-Ever Cross-Stakeholder Consensus Definition of “Patient Engagement in Research”
Value in Health announced the publication of results of an ISPOR systematic review and analysis resulting in a proposed definition of “patient engagement in research.”
Healthcare Time-Driven Activity-Based Costing Should Be Viewed as a Gold Standard
Value in Health announced today the publication of results of a study suggesting that time-driven activity-based costing can be an effective technique to support value-based healthcare initiatives.
Moving Precision Medicine From Evaluation Into Practice and Policy
Value in Health announced today the publication of a series of articles focused on methods for moving from the evaluation of precision medicine into practice and policy.
Is There a Future for Biopharmaceutical Value-Based Contracting?
Value in Health announced today the publication of a series of articles providing perspectives on biopharmaceutical value-based contracting and what the future may hold for risk-sharing arrangements.
Uptake of Lung Cancer Screening May Depend on Making Testing Fast and Convenient
Value in Health announced today the publication of new research showing that uptake of lung cancer screening may depend on making testing fast and convenient.
Incorporating Patients’ Perspectives in the Medical Device Regulatory Process
Value in Health announced today the publication of an article highlighting US Food and Drug Administration (FDA) guidance and lessons learned regarding the use of patient preference information for FDA decision making about medical devices.
ISPOR Value of Information Task Force Publishes Two New Good Practices Reports
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of 2 Good Practices Reports that provide consensus guidance on Value of Information Analysis.
Formulary Exclusions and Prior Authorization Requirements Continue to Limit Patient Access to PCSK9is
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing that insurer approval rates for PCSK9i prescriptions remain low.
Electronic Medical Record-Embedded Clinical Decision Support System for Opioid Prescribing Shows Mixed Outcomes
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of new research showing mixed clinical results of an electronic medical record-embedded clinical decision support system for opioid prescribing.
Health Technology Assessment Around the World: Broadening the Understanding of Cross-Country Differences
Value in Health announced today the publication of a series of articles investigating the use of health technology assessment (HTA) in healthcare decision making across the globe. The series, “HTA Around the World—Influences of Culture, Values, and Institutions,” appears in the January 2020 issue of Value in Health.
Introducing “Health Years in Total:” A Novel Framework for Valuing Health Outcomes in Cost-Effectiveness Analyses
Lawrenceville, NJ, USA—January 21, 2020—Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of an article introducing a new framework for valuing health outcomes in cost-effectiveness analyses. This new…
ISPOR Recognized by MarCom Awards for Its Annual Report and Rebranding of Value in Health
ISPOR—the professional society for health economics and outcomes research (HEOR), announced that it has won a number of MarCom Awards recognizing the rebranding of its high-impact journal Value in Health and its 2018 Annual Report.
New Research Confirms the Importance of Collecting Country-Specific Cost Data in the Treatment of Alzheimer’s Disease
Value in Health, the official journal of ISPOR, announced today the publication of an analysis showing that direct medical costs are the major cost driver of Alzheimer’s disease care in Thailand, a finding distinct from other countries across the world.
Systematic Collection of Patient-Reported Outcome Measures in Breast Cancer Care Has a Promising Impact on Patients, Providers, and Care Processes
Value in Health, the official journal of ISPOR, announced the publication of new research showing that systematic collection of patient-reported outcome measures in breast cancer care has a promising impact on patients, providers, and care processes/systems.
Expert Analysis: Healthcare Value Assessment Frameworks Have Advanced, But Wholesale Adoption Still Not Wise
Value in Health, the official journal of ISPOR, announced the publication of an analysis showing that while value assessment frameworks are moving closer to meeting the challenge of accurately measuring value and informing healthcare decisions, more progress is needed before widespread adoption and use.
Can Discrete Choice Experiment Technique Predict Real-World Healthcare Decisions?
Value in Health, the official journal of ISPOR—the professional society for health economics and outcomes research, announced today the publication of research demonstrating that discrete choice experiments are able to predict real-world healthcare choices.